Overview

A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and Lamivudine

Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study will see how safe and effective against HIV the drugs L-756423 plus indinavir (IDV) are compared to just IDV when taken with stavudine (d4T) and lamivudine (3TC). The study will also see whether taking 1 large dose of L-756423/IDV once a day is as safe and effective as taking 2 smaller doses twice a day.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Indinavir
Lamivudine
Stavudine